Incyte (INCY) EBT Margin Growth (3y) (2013 - 2026)
Incyte (INCY) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 2,059.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,059.00 |
| Dec 31, 2025 | 1,718.00 |
| Sep 30, 2025 | 1,726.00 |
| Jun 30, 2025 | 2,074.00 |
| Mar 31, 2025 | 1,262.00 |
| Dec 31, 2024 | 1,271.00 |
| Sep 30, 2024 | -1,201.00 |
| Jun 30, 2024 | -6,166.00 |
| Mar 31, 2024 | 1,535.00 |
| Dec 31, 2023 | 545.00 |
| Sep 30, 2023 | 2,601.00 |
| Jun 30, 2023 | -1,558.00 |
| Mar 31, 2023 | 13,026.00 |
| Dec 31, 2022 | -1,305.00 |
| Sep 30, 2022 | -879.00 |
| Jun 30, 2022 | 466.00 |
| Mar 31, 2022 | -1,129.00 |
| Dec 31, 2021 | 53.00 |
| Sep 30, 2021 | 1,888.00 |
| Jun 30, 2021 | 1,396.00 |